Predicting the public health benefit of vaccinating cattle against Escherichia coli O157
暂无分享,去创建一个
George J. Gunn | Louise Matthews | Daniel T. Haydon | Richard Reeve | Mark E. J. Woolhouse | M. Woolhouse | L. Matthews | M. Chase-Topping | D. Haydon | R. Reeve | S. McAteer | D. Gally | G. Gunn | L. Allison | Sean P. McAteer | David L. Gally | S. Reid | J. Chris Low | Mary E. Locking | Margo E. Chase-Topping | Lesley J. Allison | Mary F. Hanson | Stuart W. J. Reid | M. Hanson | C. Low | J. Low | M. Locking
[1] E. Lichtenberg. The Economics of Reducing Health Risk from Food , 1995 .
[2] Gehua Wang,et al. Detection in Escherichia coli of the Genes Encoding the Major Virulence Factors, the Genes Defining the O157:H7 Serotype, and Components of the Type 2 Shiga Toxin Family by Multiplex PCR , 2002, Journal of Clinical Microbiology.
[3] T. Pennington,et al. Long‐term survival of Escherichia coli O157 on pasture following an outbreak associated with sheep at a scout camp , 2002, Letters in applied microbiology.
[4] F. Dziva,et al. Options for the control of enterohaemorrhagic Escherichia coli in ruminants. , 2002, Microbiology.
[5] G. Gunn,et al. A comparison of two pre‐enrichment media prior to immunomagnetic separation for the isolation of E. coli O157 from bovine faeces , 2003, Journal of applied microbiology.
[6] G. Carrin,et al. Human health benefits from livestock vaccination for brucellosis: case study. , 2003, Bulletin of the World Health Organization.
[7] Gilbert S Chen,et al. Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. , 2003, The Journal of infectious diseases.
[8] L Matthews,et al. Super-shedding cattle and the transmission dynamics of Escherichia coli O157 , 2005, Epidemiology and Infection.
[9] L Matthews,et al. Heterogeneous shedding of Escherichia coli O157 in cattle and its implications for control. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[10] N. Strachan,et al. Escherichia coli O157: burger bug or environmental pathogen? , 2006, International journal of food microbiology.
[11] Mahamat Bechir Mahamat,et al. Potential of cooperation between human and animal health to strengthen health systems , 2005, The Lancet.
[12] J. Bono,et al. Greater Diversity of Shiga Toxin-Encoding Bacteriophage Insertion Sites among Escherichia coli O157:H7 Isolates from Cattle than in Those from Humans , 2006, Applied and Environmental Microbiology.
[13] M. J. Smith,et al. Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[14] Marcel Tanner,et al. Human Benefits of Animal Interventions for Zoonosis Control , 2007, Emerging infectious diseases.
[15] T. Hindré,et al. Shiga Toxin Produced by Enterohemorrhagic Escherichia coli Inhibits PI3K/NF-κB Signaling Pathway in Globotriaosylceramide-3-Negative Human Intestinal Epithelial Cells1 , 2007, The Journal of Immunology.
[16] B. Levin,et al. Grazing protozoa and the evolution of the Escherichia coli O157:H7 Shiga toxin-encoding prophage , 2007, Proceedings of the Royal Society B: Biological Sciences.
[17] F. Scheutz,et al. Subtyping Method for Escherichia coli Shiga Toxin (Verocytotoxin) 2 Variants and Correlations to Clinical Manifestations , 2007, Journal of Clinical Microbiology.
[18] M. Woolhouse,et al. Risk Factors for the Presence of High-Level Shedders of Escherichia coli O157 on Scottish Farms , 2007, Journal of Clinical Microbiology.
[19] T. Hindré,et al. Shiga toxin produced by enterohemorrhagic Escherichia coli inhibits PI3K/NF-κB signaling pathway in globotriaosylceramide-3-negative human intestinal epithelial cells. , 2008, The Journal of Immunology.
[20] M. Woolhouse,et al. Super-shedding and the link between human infection and livestock carriage of Escherichia coli O157 , 2008, Nature Reviews Microbiology.
[21] S. E. Robinson,et al. Quantifying within- and between-animal variation and uncertainty associated with counts of Escherichia coli O157 occurring in naturally infected cattle faeces , 2009, Journal of The Royal Society Interface.
[22] J. T. Fox,et al. Efficacy of Escherichia coli O157:H7 siderophore receptor/porin proteins-based vaccine in feedlot cattle naturally shedding E. coli O157. , 2009, Foodborne pathogens and disease.
[23] D. Fisman,et al. The sounds of silence: Public goods, externalities, and the value of infectious disease control programs. , 2009, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.
[24] Ram N. Acharya,et al. Public Goods, Hysteresis, and Underinvestment in Food Safety , 2009 .
[25] Tanya Roberts,et al. The economics of enteric infections: human foodborne disease costs. , 2009, Gastroenterology.
[26] D. Thomson,et al. Use of a siderophore receptor and porin proteins-based vaccine to control the burden of Escherichia coli O157:H7 in feedlot cattle. , 2009, Foodborne pathogens and disease.
[27] D. Mellor,et al. Exploiting strain diversity to expose transmission heterogeneities and predict the impact of targeting supershedding. , 2009, Epidemics.
[28] J. D. Greig,et al. Analysis of foodborne outbreak data reported internationally for source attribution. , 2009, International journal of food microbiology.
[29] John Cowden,et al. Escherichia coli O157 , 2009, BMJ : British Medical Journal.
[30] M. Penny,et al. Transmission dynamics and economics of rabies control in dogs and humans in an African city , 2009, Proceedings of the National Academy of Sciences.
[31] James O. Lloyd-Smith,et al. Epidemic Dynamics at the Human-Animal Interface , 2009, Science.
[32] David G. E. Smith,et al. Immunization of cattle with a combination of purified intimin-531, EspA and Tir significantly reduces shedding of Escherichia coli O157:H7 following oral challenge. , 2010, Vaccine.
[33] E. Franz,et al. Genetic Features Differentiating Bovine, Food, and Human Isolates of Shiga Toxin-Producing Escherichia coli O157 in The Netherlands , 2011, Journal of Clinical Microbiology.
[34] J. Haagsma,et al. Cost of illness and disease burden in The Netherlands due to infections with Shiga toxin-producing Escherichia coli O157. , 2011, Journal of food protection.
[35] A. Weiss,et al. Shiga Toxin Subtypes Display Dramatic Differences in Potency , 2011, Infection and Immunity.
[36] J. Cowden,et al. Escherichia coli O157 Infection and Secondary Spread, Scotland, 1999–2008 , 2011, Emerging infectious diseases.
[37] B. Bonfoh,et al. Representative Seroprevalences of Brucellosis in Humans and Livestock in Kyrgyzstan , 2011, EcoHealth.
[38] K. Stanford,et al. Genetic diversity and antimicrobial resistance among isolates of Escherichia coli O157: H7 from feces and hides of super-shedders and low-shedding pen-mates in two commercial beef feedlots , 2012, BMC Veterinary Research.
[39] Thomas E. Besser,et al. Phylogeny of Shiga Toxin-Producing Escherichia coli O157 Isolated from Cattle and Clinically Ill Humans , 2012, Molecular biology and evolution.
[40] J. Sargeant,et al. A Systematic Review of Vaccinations to Reduce the Shedding of Escherichia coli O157 in the Faeces of Domestic Ruminants , 2012, Zoonoses and public health.
[41] R. Scharff,et al. Economic burden from health losses due to foodborne illness in the United States. , 2012, Journal of food protection.
[42] H. S. Hurd,et al. An outcomes model to evaluate risks and benefits of Escherichia coli vaccination in beef cattle. , 2012, Foodborne pathogens and disease.
[43] S. Beatson,et al. Lysogeny with Shiga Toxin 2-Encoding Bacteriophages Represses Type III Secretion in Enterohemorrhagic Escherichia coli , 2012, PLoS pathogens.
[44] C. Narrod,et al. A One Health Framework for Estimating the Economic Costs of Zoonotic Diseases on Society , 2012, EcoHealth.
[45] P. Dick,et al. Assessing the Existing Information on the Efficacy of Bovine Vaccination against Escherichia coli O157:H7 – A Systematic Review and Meta‐analysis , 2013, Zoonoses and public health.